Research progress of nucleocapsid protein of novel coronavirus: structure, function and targeted therapy
Archives of Virology · 2026-04 · 171 (4)
DOI: 10.1007/s00705-026-06569-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Virology, online erschienen am 10.03.2026. Verfasst von Xie Moyue und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hubei University of Arts and Science Affiliated Hospital Xiangyang Central Hospital, Xiangyang, Hubei, 441021, China. Hauptthemen laut MEDLINE: Coronavirus Nucleocapsid Proteins, Nucleocapsid Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The outbreak of COVID-19 caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 poses an ongoing threat to global public health security. The continuous evolution of viruses (e.g., Delta, Omicron) has increased the risk of viral transmissibility, infectivity, and the risk of immune escape. As highly conserved structural proteins of viruses, nucleocapsid proteins (N proteins) play a central role in the viral life cycle, and the study of their functional mechanisms and targeted therapeutics is crucial for the development of antiviral strategies. In this paper, we systematically describe the structural characterization, functional mechanism, and targeted therapy of the SARS-CoV-2 N protein, analyze its key roles in viral packaging, replication, and immune escape, and discuss the challenges and future directions of drug development for the N protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei University of Arts and Science Affiliated Hospital Xiangyang Central Hospital, Xiangyang, Hubei, 441021, China.
- Central Laboratory, Xiangyang Central Hospital Affiliated to Hubei University of Arts and Science, Xiangyang, 441021, Hubei, China.
- Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital, National Clinical Research Center for infectious disease, Southern Univers…
- Office of Infection and Control, Xiangyang Central Hospital, Hubei University of Arts and Science, Jingzhou Street 39, Xiangcheng District, Xiangyang, Hubei, 441021, China. 50275@hbuas.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Moyue, X., Liang, S., Ying, X., Yang, Y., & Dongang, Z. (2026). Research progress of nucleocapsid protein of novel coronavirus: structure, function and targeted therapy. Archives of Virology, 171(4). https://doi.org/10.1007/s00705-026-06569-6
Vancouver
Moyue X, Liang S, Ying X, Yang Y, Dongang Z. Research progress of nucleocapsid protein of novel coronavirus: structure, function and targeted therapy. Archives of Virology. 2026;171(4). doi:10.1007/s00705-026-06569-6
BibTeX
@article{Moyue2026,
author = {Moyue, Xie and Liang, Shen and Ying, Xia and Yang, Yang and Dongang, Zhan},
title = {Research progress of nucleocapsid protein of novel coronavirus: structure, function and targeted therapy},
journal = {Archives of Virology},
year = {2026},
volume = {171},
number = {4},
doi = {10.1007/s00705-026-06569-6}
}
EUVIMED